Skip to main content
. 2012 May 30;120(8):1581–1588. doi: 10.1182/blood-2012-02-408336

Figure 7.

Figure 7

Relapse-free survival on the basis of the presence or absence of residual disease (RD). Relapse-free survival on the basis of the presence or absence of RD in patients with standard-risk (A), favorable-risk (B) or high-risk (C) acute myeloid leukemia.